Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index for Classification of Patients with Steatotic Liver Disease

被引:1
|
作者
Roy, Akash [1 ]
De, Arka [2 ]
Kulkarni, Anand V. [3 ]
Jajodia, Surabhi [4 ]
Goenka, Usha [4 ]
Tewari, Awanish [1 ]
Sonthalia, Nikhil [1 ]
Goenka, Mahesh K. [1 ]
机构
[1] Apollo Multispecial Hosp, Inst Gastrosci & Liver Transplantat, Kolkata, India
[2] Post Grad Inst Med Educ & Res, Dept Hepatol, Chandigarh, India
[3] Asian Inst Gastroenterol, Dept Hepatol, Hyderabad, India
[4] Apollo Multispecial Hosp, Dept Radiol & Imaging, Kolkata, India
关键词
Non-alcoholic fatty liver disease; Liver steatosis; Alcoholic fatty liver; GAMMA-GLUTAMYL-TRANSFERASE;
D O I
10.7570/jomes23063
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Steatotic liver disease (SLD) encompasses metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-associated liver disease (AALD) at extremes as well as an overlap group termed MASLD with increased alcohol intake (MetALD). The Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index (ANI) was proposed to differentiate ALD from nonalcoholic fatty liver disease (NAFLD). We analysed the performance of the ANI in differentiating within the SLD spectrum. Methods: In a cross-sectional study at a tertiary care center, 202 adults (>18 years) who were prospectively diagnosed with SLD defined by magnetic resonance imaging-proton density fat fraction > 6.4% were enrolled. Alcohol consumption (AC) was recorded according to thresholds for significant AC: 140-350 g/week (or 20- 50 g/day) for females and 210-420 g/week (or 30-60 g/day) for males. The ANI was calculated, and area under the receiver operating characteristic curve (AUROC) was generated. Results: Of 202 patients (47 years [interquartile range, IQR, 38 to 55], 23.75% females, 77% obese, 42.1% with diabetes, 38.1% hypertensive, 28.7% statin use), 40.5% were ever-alcohol consumers; 120 (59%), 50 (24.7%), and 32 (15.8%) were MASLD (ANI, -3.7 [IQR, -7 to -1.6]; MetALD, - 1.45 [IQR, -2.4 to 0.28]; and AALD, 0.71 [IQR, -1.3 to 4.8], respectively; P< 0.05 for all). The AUROC of the ANI for MASLD and AALD was 0.79 (IQR, 0.72 to 0.84; cut-off < -3.5) and 0.80 (IQR, 0.74 to 0.86; cut-off > -1.49), respectively. The ANI outperformed aspartate transaminase/alanine transaminase (AST/ALT) ratio (AUROC=0.75 [IQR, 0.69 to 0.81]) and gamma glutamyl transpeptidase (GGT) (AUROC=0.74 [IQR, 0.67 to 0.80]). Addition of GGT did not improve model performance (AUCdiff=0.004; P= 0.33). Conclusion: AC is common in MASLD. The ANI distinguishes MASLD and AALD, with individual cut-offs within the intermediate zone indicating MetALD. ANI also outperforms AST/ALT ratio or GGT.
引用
收藏
页码:222 / 228
页数:7
相关论文
共 50 条
  • [41] Liver regeneration in nonalcoholic fatty liver disease
    Lagomarsino, Aldo
    MEDWAVE, 2012, 12 (11):
  • [42] Beyond Nonalcoholic Fatty Liver Disease: The Expansive Realm of Metabolic Dysfunction-associated Steatotic Liver Disease
    Samadarshi, Samir
    Kumar, Dharmendra
    Manrai, Manish
    Dawra, Saurabh
    Srivastava, Sharad
    Chandra, Alok
    JOURNAL OF MARINE MEDICAL SOCIETY, 2025, 27 (01) : 54 - 58
  • [43] Obesity and the liver: nonalcoholic fatty liver disease
    Koppe, Sean W. P.
    TRANSLATIONAL RESEARCH, 2014, 164 (04) : 312 - 322
  • [44] Alcoholic and Nonalcoholic Fatty Liver Disease and Incident Hospitalization for Liver and Cardiovascular Diseases
    Chang, Yoosoo
    Cho, Juhee
    Cho, Yong Kyun
    Cho, Ara
    Hong, Yun Soo
    Zhao, Di
    Ahn, Jiin
    Sohn, Chong Il
    Shin, Hocheol
    Guallar, Eliseo
    Ryu, Seungho
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (01) : 205 - +
  • [45] Nonalcoholic fatty liver disease and liver transplantation
    Angulo, P
    LIVER TRANSPLANTATION, 2006, 12 (04) : 523 - 534
  • [46] IS LIVER BIOPSY NECESSARY IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE?
    Gavril, R. S.
    Mihalache, Laura
    Arhire, Lidia
    Grosu, Cristina
    Gherasim, Andreea
    Nita, Otilia
    Oprescu, A. C.
    Graur, Mariana
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2016, 120 (03): : 503 - 507
  • [47] Prevalence and Severity of Nonalcoholic Fatty Liver Disease Among Caregivers of Patients With Nonalcoholic Fatty Liver Disease Cirrhosis
    Siddiqui, Mohammad Shadab
    Carbone, Salvatore
    Vincent, Robert
    Patel, Samarth
    Driscoll, Carolyn
    Celi, Francesco S.
    Billingsley, Hayley
    Rotelli, Brando
    John, Binu
    Potere, Nicola
    Viscusi, Michele
    Adiletta, Veronica
    Sanyal, Arun J.
    Luketic, Velimir A.
    Reichman, Trevor
    Bhati, Chandra S.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (10) : 2132 - 2133
  • [48] Liver pathology in patients with suspected nonalcoholic fatty liver disease
    Meier, Korrin
    Komorowski, Richard
    Wallace, James
    Nuttleman, Peter
    Andris, Deborah
    Gawrieh, Sumer
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 128 (04) : 708 - 708
  • [49] Nonalcoholic Fatty Liver Disease
    Wang, Xiao Jing
    Malhi, Harmeet
    ANNALS OF INTERNAL MEDICINE, 2018, 169 (09) : ITC65 - ITC80
  • [50] Nonalcoholic Fatty Liver Disease
    Sweet, Patrick H.
    Khoo, Teresa
    Nguyen, Steven
    PRIMARY CARE, 2017, 44 (04): : 599 - +